We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 877 results
  1. Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

    Background

    Lung adenocarcinoma (LUAD) is an extraordinarily malignant tumor, with rapidly increasing morbidity and poor prognosis. Immunotherapy has...

    Qianhe Ren, Qifan Li, ... Yue Yu in BMC Cancer
    Article Open access 23 September 2023
  2. Pan-cancer analysis identifies BIRC5 as a prognostic biomarker

    Background

    The BIRC5 gene encodes for the Survivin protein, which is a member of the inhibitor of apoptosis family. Survivin is found in humans...

    Anna Fäldt Beding, Peter Larsson, ... Toshima Z. Parris in BMC Cancer
    Article Open access 25 March 2022
  3. BIRC5 regulates inflammatory tumor microenvironment-induced aggravation of penile cancer development in vitro and in vivo

    Background

    Baculoviral IAP repeat containing 5 (BIRC5) is overexpressed and plays as a key regulator in the progression of various human carcinomas....

    Yang Zhao, Songlin Liu, ... Yinxu Wan in BMC Cancer
    Article Open access 23 April 2022
  4. Upregulation of Nox4 induces a pro-survival Nrf2 response in cancer-associated fibroblasts that promotes tumorigenesis and metastasis, in part via Birc5 induction

    Background

    A pro-oxidant enzyme, NADPH oxidase 4 (Nox4) has been reported to be a critical downstream effector of TGFβ-induced myofibroblast...

    Shakeel Mir, Briana D. Ormsbee Golden, ... Melissa LT. Teoh-Fitzgerald in Breast Cancer Research
    Article Open access 14 July 2022
  5. miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5

    Background

    miR-198 is involved in the formation, migration, invasion, and metastasis of various malignant cancers. However, the function and mechanism...

    Chao Yuan, Zhenhong Su, ... **n Yu in Cancer Cell International
    Article Open access 21 July 2021
  6. hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression

    Background

    Systematic profiling studies have implicated regulators of pre-mRNA splicing as important disease determinants in gastric cancer (GC), but...

    Wei-zhao Peng, ** Zhao, ... Ren Ma in Cancer Cell International
    Article Open access 27 May 2021
  7. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma

    The incidence of renal cell carcinoma (RCC) is increasing worldwide with an approximate 20% mortality rate. The challenge in RCC is the...

    Fengzhi Li, Ieman A. M. Aljahdali, ... **ang Ling in Journal of Experimental & Clinical Cancer Research
    Article Open access 12 August 2021
  8. Malignant peritoneal mesothelioma interactome with 417 novel protein–protein interactions

    Background

    Malignant peritoneal mesothelioma (MPeM) is an aggressive cancer affecting the abdominal peritoneal lining and intra-abdominal organs, with...

    Kalyani B. Karunakaran, Madhavi K. Ganapathiraju in BJC Reports
    Article Open access 24 May 2024
  9. IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression

    Background

    Neuroblastoma is the most common solid tumor in infants accounting for approximately 15% of all cancer-related deaths. Over 50% of...

    Sven Hagemann, Danny Misiak, ... Stefan Hüttelmaier in Molecular Cancer
    Article Open access 29 May 2023
  10. Lnc Tmem235 promotes repair of early steroid-induced osteonecrosis of the femoral head by inhibiting hypoxia-induced apoptosis of BMSCs

    Bone marrow mesenchymal stem cells (BMSCs) have been used in the treatment of early steroid-induced osteonecrosis of the femoral head (SONFH)....

    Fei Zhang, Wuxun Peng, ... Gang Liu in Experimental & Molecular Medicine
    Article Open access 16 November 2022
  11. TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cells

    Genetic alterations have been reported for decades in most human embryonic stem cells (hESCs). Survival advantage, a typical trait acquired during...

    Yun-Jeong Kim, Young-Hyun Go, ... Hyuk-** Cha in Experimental & Molecular Medicine
    Article Open access 04 January 2023
  12. Exosome-Mediated Communication in Thyroid Cancer: Implications for Prognosis and Therapeutic Targets

    Thyroid cancer (THCA) is one of the most common malignancies of the endocrine system. Exosomes have significant value in performing molecular...

    Yiwei Wang, Qiang Li, ... Fu Ren in Biochemical Genetics
    Article 05 June 2024
  13. Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma

    Background

    Receptor-type tyrosine-protein phosphatase T (PTPRT) is a transmembrane protein that is involved in cell adhesion. We previously found that

    Chao Chen, Haozhen Liu, ... Jixian Liu in BMC Cancer
    Article Open access 12 January 2024
  14. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification

    Background

    Chronic hepatitis B virus (HBV) infection is the major etiology of hepatocellular carcinoma (HCC). However, the mechanism of hepatitis...

    Shenghao Li, Liyuan Hao, ... Luya Li in Infectious Agents and Cancer
    Article Open access 01 July 2023
  15. Screening of small molecule compounds targeting hnRNPA2 protein

    Heterogeneous nuclear ribonucleoprotein A2, as an RNA binding protein, participates in the processing and metabolism of RNA molecules. HnRNPA2 is...

    Yuan-Rong Zheng, Chao-Jie Wang, ... Song-Lin Shi in Medicinal Chemistry Research
    Article 28 October 2023
  16. FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid rafts

    Fibroblast activation protein (FAP) is tumor-specific and plays an important role in tumorigenecity. However, agents against its enzymatic activity...

    Bin Li, Zuo Ding, ... Shuang Huang in Cancer Gene Therapy
    Article 09 December 2022
  17. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer

    Background

    Globally, endometrial cancer is the fourth most common malignant tumor in women and the number of women being diagnosed is increasing....

    Jun Zhang, Ziwei Wang, ... Hongbo Wang in BMC Cancer
    Article Open access 27 October 2020
  18. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro

    Lung cancer is the second most prevalent type of cancer and is responsible for the highest number of cancer-related deaths worldwide. Non-small-cell...

    Bikash Manandhar, Keshav Raj Paudel, ... Kamal Dua in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 13 July 2023
  19. Exploration of subtype-specific perturbations in breast cancer

    Breast cancer remains a leading cause of mortality among women, characterized by its complex and diverse nature, comprising various molecular...

    Garhima Arora, Poulomi Chatterjee, Samrat Chatterjee in Journal of Proteins and Proteomics
    Article 01 July 2024
  20. New insights into the ambivalent role of YAP/TAZ in human cancers

    Hippo signaling was first identified in Drosophila as a key controller of organ size by regulating cell proliferation and anti-apoptosis. Subsequent...

    Juan Luo, Liang Deng, ... Peng Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 22 May 2023
Did you find what you were looking for? Share feedback.